Mar 8

Amniotic Fluid Products Probably Don’t Contain Stem Cells, but May Still Modulate Healing

In vivo amniotic fluid is known to contain growth factors and mesenchymal stem cells (MSCs), which prior research has suggested may aid in tissue healing. Several companies have injectable amniotic fluid products  (AFPs) on the market based on this  prior research, but it’s unclear exactly what the composition of these AFPs is and whether they contain viable MSCs that could participate in healing. To clarify these lingering questions, upcoming TOBI conference speaker Dr. Panero and several of his colleagues at...

Jan 20

The Influence of Naproxen on Biological Factors in Leukocyte-Rich PRP: A Prospective Study

Chahla et al 2019 (NSAIDS) Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) consists of blood plasma with higher concentrations of platelets and leukocytes than typically available in a normal blood draw, and is commonly used to treat musculoskeletal injuries through regenerative processes in the body.  Oftentimes, concentrations of platelets and leukocytes are highly variable in a given therapeutic sample, as well as the methods of preparing that biological product and the demographic characteristics from which the blood sample was drawn. All these factors,...

Jan 16

Comparing PRP to Tenex in the treatment of medial and lateral epicondylitis

[section_tc][column_tc span='12'][text_tc trigger_pt='0' duration='1000' delay='0']Medial and lateral epicondylitis are two common elbow conditions that affect a variety of athletes and can significantly impair arm function. While epicondylitis generally responds to conservative treatment, the course can be prolonged and it’s unclear whether some treatments may work better than others. In a study published in the Journal of Shoulder and Elbow Surgery, several authors including TOBI faculty Drs. Kenneth Mautner and Allison Boden compared the effectiveness of platelet-rich plasma (PRP) and Tenex...